Real Time Touch

new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)

Real Time Touch

Miragen Therapeutics Inc patents

Recent patent applications related to Miragen Therapeutics Inc. Miragen Therapeutics Inc is listed as an Agent/Assignee. Note: Miragen Therapeutics Inc may have other listings under different names/spellings. We're not affiliated with Miragen Therapeutics Inc, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "M" | Miragen Therapeutics Inc-related inventors

Inhibitors of myh7b and uses thereof

The present invention provides nucleic acid inhibitors of MYH7B and compositions thereof. The present invention also provides methods of treating or preventing a cardiac disorder such as cardiac hypertrophy, myocardial infarction, or heart failure in a subject by administering to the subject an inhibitor of MYH7B. The present invention further... Miragen Therapeutics Inc

Mirna mimetics and their use in treating sensory conditions

The present invention provides microRNA mimetic compounds that mimic the function or activity of miR-96, miR-182, and/or miR-183. The microRNA mimetic compounds of the invention comprise a first strand of about (22) to about (26) ribonucleotides comprising a mature miR-96, miR-182, or miR-183 sequence; and a second strand of about... Miragen Therapeutics Inc

Oligonucleotide compositions and uses thereof

The present invention provides oligonucleotide inhibitors of miR-155 and compositions thereof. The invention further provides methods for treating cancer such as a T cell lymphoma in a subject by administering to the subject an oligonucleotide inhibitor of miR-155. The invention also provides methods for reducing or inhibiting the proliferation of... Miragen Therapeutics Inc

Synthesis of bicyclic nucleosides

The present disclosure provides methods for synthesizing modified nucleosides, nucleotides, and oligonucleotides comprising at least one 2′-C-Bridged Bicyclic Nucleotide, and to intermediates used in the process.... Miragen Therapeutics Inc

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009


This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. is not affiliated or associated with Miragen Therapeutics Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Miragen Therapeutics Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by